4D Molecular Therapeutics, Inc. (FDMT) - Company Revenue

4D Molecular Therapeutics, Inc. (FDMT) - corporate logo

The high margin potential of 4D Molecular Therapeutics (FDMT) is based on cutting-edge IT developments in the field of DNA vector maturation. The company's gross sales volume trend visualizes the intensity of demand, where 0.10 represents the current metric. Despite fierce competition with pharma behemoths for investment, the massive deferred demand for macular dystrophy treatment paves the way for a large-scale expansion of the customer base.

4D Molecular Corp (FDMT): Revenue and Sales Volume from 07/04/2022 to 11/17/2026

FDMT (4D Molecular Corp): analytical breakdowns and indicator data

Basic company analysis:FDMT, 4dmoleculartherapeutics.com
Signature product of 4D Molecular Therapeutics Inc

Investors are searching 4D Molecular Therapeutics (FDMT) financial reports for sustainable fundamental benchmarks to assess business value. This metric captures daily operational cash flow without time lags. Analyzing the volume of products sold by 4D Molecular Therapeutics (FDMT) allows for the timely detection of revenue declines and prevents purchasing the asset at its peak. For this biopharmaceutical pioneer in gene therapy, such a metric confirms the commercial demand for its DNA vector IT platform. Monitoring revenue objectifies the company's scientific potential through the lens of actual market inflows.

Competitor analysis

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales